Ovid Therapeutics Inc. (FRA:1OT)

Ovid Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	187	64	206	123	192	120
Market Cap Growth	188.16%	-68.90%	67.89%	-36.19%	60.44%	-32.26%
Enterprise Value	177	18	142	9	15	49
Last Close Price	1.44	0.89	3.00	1.68	2.74	1.83
PE Ratio	-	-	-	-	1.82	-
PS Ratio	33.18	117.14	580.59	87.22	1.05	11.61
PB Ratio	4.91	0.97	2.59	0.99	1.22	3.36
P/TBV Ratio	4.91	0.97	2.60	0.99	1.22	3.38
P/FCF Ratio	-	-	-	-	1.85	-
P/OCF Ratio	-	-	-	-	1.84	-
EV/Sales Ratio	31.10	32.98	400.05	6.30	0.08	4.73
EV/EBITDA Ratio	-	-	-	-	0.14	-
EV/EBIT Ratio	-	-	-	-	0.14	-
EV/FCF Ratio	-5.46	-	-	-	0.14	-
Debt / Equity Ratio	0.31	0.22	0.18	0.13	-	-
Asset Turnover	0.08	0.01	0.00	0.01	1.54	0.16
Quick Ratio	3.77	5.04	9.23	18.45	12.69	3.27
Current Ratio	4.24	5.32	9.55	18.79	12.87	3.39
Return on Equity (ROE)	-60.06%	-33.88%	-47.57%	-34.72%	109.98%	-142.60%
Return on Assets (ROA)	-29.33%	-30.90%	-24.05%	-19.85%	57.40%	-64.93%
Return on Capital (ROIC)	-32.59%	-39.07%	-28.49%	-21.13%	69.51%	-89.56%
Return on Capital Employed (ROCE)	-68.50%	-71.50%	-43.40%	-37.50%	69.10%	-151.20%
Earnings Yield	-16.36%	-39.87%	-23.00%	-41.33%	56.20%	-55.30%
FCF Yield	-17.31%	-84.50%	-20.13%	-43.07%	54.18%	-35.29%
Buyback Yield / Dilution	-0.35%	-0.46%	-0.22%	-3.46%	-16.45%	-49.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.